NCT07129252
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07129252
Title A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors (BRAVESST2)
Acronym BRAVESST2
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Crinetics Pharmaceuticals Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP


No variant requirements are available.